Reply to: “Evidence-based guidelines for tuberculosis screening before biologic treatment initiation” - 19/06/20
Doi : 10.1016/j.jaad.2020.03.039
Anthony P. Fernandez, MD, PhD a, b, ⁎ 
, Ariana Ellis, BS a, c, Urmi Khanna, MD a, AbdulAziz Galadari, MD a
, Ariana Ellis, BS a, c, Urmi Khanna, MD a, AbdulAziz Galadari, MD a a Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
b Department of Pathology, Cleveland Clinic, Cleveland, Ohio
c Northeast Ohio Medical University, Rootstown, Ohio
∗Correspondence to: Anthony P. Fernandez, MD, PhD, Departments of Dermatology and Pathology, Cleveland Clinic, 9500 Euclid Ave, A61, Cleveland, OH 44195Departments of Dermatology and PathologyCleveland Clinic9500 Euclid Ave, A61ClevelandOH44195
Il testo completo di questo articolo è disponibile in PDF.
| Funding sources: None. |
|
| Conflicts of interest: Dr Fernandez receives research support from Mallinckrodt, Corbus, Pfizer, and Novartis and honorarium from AbbVie, Novartis, UCB, and Mallinckrodt for consulting, advisory board participation, and speaking. Drs Khanna and Galadari and Ms Ellis have no conflicts of interest to declare. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 83 - N° 1
P. e27-e28 - luglio 2020 Ritorno al numero
Articolo precedente
- Evidenced-based guidelines for tuberculosis screening before biologic treatment initiation
- Payal Shah, Gabriel Rebick, Shirin Bajaj, Ludovic Desvignes, Kristen Lo Sicco
- Recommendations on dermatologic surgery during the COVID-19 pandemic
- Samuel Antranig Der Sarkissian, Leo Kim, Michael Veness, Eleni Yiasemides, Deshan Frank Sebaratnam
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?